Abstract:In this study, glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles were prepared to establish a tumor targeting nano-sized drug delivery system. Glycyrrhizic acid was coupled to human serum albumin, and resveratrol was encapsulated in glycyrrhizic acid-conjugated human serum albumin by high-pressure homogenization emulsification. The average particle size of sample nanoparticles prepared under the optimal conditions was 108.1 +/- 5.3 nm with a polydispersity index (PDI) of 0.001, and the amount of glycyrrhizic acid coupled with human serum albumin was 112.56 mu g/mg. The drug encapsulation efficiency and drug loading efficiency were 83.6 and 11.5%, respectively. The glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles were characterized through laser light scattering, scanning electron microscopy, Fourier-transform infrared spectroscopy, X-ray diffraction, differential scanning calorimetry, thermogravimetric analyses, and gas chromatography. The characterization results showed that resveratrol in glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles existed in amorphous state and the residual amounts of chloroform and methanol in nanoparticles were separately less than the international conference on harmonization (ICH) limit. The in vitro drug-release study showed that the nanoparticles released the drug slowly and continuously. The inhibitory rate of glycyrrhizic acidconjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles was measured using 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl-2 H-tetrazolium bromide method. The IC50 values of glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles and resveratrol were 62.5 and 95.5 mu g/ml, respectively. The target ability of glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles for HepG2 cells was evaluated using fluorescence-modified albumin techniques. The uptake rate of glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles was higher than that of pure resveratrol and increased with increased nanoparticles concentration. The in vivo body distribution of glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles labeled with the near-infrared fluorophore Cy5 was monitored in H22 tumor-bearing mice through near-infrared fluorescence imaging systems. Glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles exhibited effective target orientation to liver tumor and sustained-release property.

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells

Evaluation of 3-O-β-D-galactosylated resveratrol-loaded polydopamine nanoparticles for hepatocellular carcinoma treatment

Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors.

Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.

Anti-Hepatocarcinoma Effects of Resveratrol Loaded Solid Nanodispersion by A New Material Nano Silica

Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol in Vitro and in Vivo.

Application of Liposome Encapsulation Technique to Improve Anti-Carcinoma Effect of Resveratrol.

Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer

Enhancing resveratrol pharmacokinetics and cytotoxicity in ovarian cancer cells via nanostructured lipid carriers

A nano-preparation approach to enable the delivery of daphnoretin to potentiate the therapeutical efficacy in hepatocellular cancer

Preparation and Biological Activity Studies of Resveratrol Loaded Ionically Cross-Linked Chitosan-Tpp Nanoparticles.

Effects of Resveratrol on Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells and Its Possible Mechanism

Folate-conjugated Human Serum Albumin-Encapsulated Resveratrol Nanoparticles: Preparation, Characterization, Bioavailability and Targeting of Liver Tumors

Anti-breast cancer activity of resveratrol encapsulated in liposomes

Enhanced Cancer Therapy of Celastrol in Vitro and in Vivo by Smart Dendrimers Delivery with Specificity and Biosafety

Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells

Polyethyleneglycol-Modified Poly(D,L-Lactide-Co-Glycolide) Loaded Resveratrol Nanoparticles Characterization and Their Anti-Cancer Activities

Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy

Functional Nanoparticles Encapsulated in Resveratrol-Formaldehyde Resin for Cancer Therapy

GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance

Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy